TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.41 0.0 (-1.14%) 0.0 (-0.3%) 0.0 (0.13%) -0.01 (-2.51%) --- --- 0.0 (-1.14%) 0.0 (-1.14%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.2075
Diluted P/E:
-0.2075
RSI(14) 1m:
49.5
VWAP:
0.4
RVol:
0.0303

Events

Period Kind Movement Occurred At
1m Price decrease 1m 0.71 -0.02 (-3.08%) Oct 15 16:25
1m Price increase 1m 0.73 +0.02 (+3.03%) Oct 15 16:21
10m Price increase 10m 0.73 +0.03 (+3.7%) Oct 15 16:21
1m Price decrease 1m 0.7 -0.02 (-2.38%) Oct 15 16:20
10m Price decrease 10m 0.7 -0.04 (-5.79%) Oct 15 16:20

Related News